BCR::ABL1-positive B-ALL is usually regarded as a “high-risk” reference [31–33], while ETV6::RUNX1-positive B-ALL is a “low-risk” reference [34]. This evidence concerns the gene ABL1 and acute lymphoblastic leukemia.